Press Releases
Scientists able to see how potential cancer treatment reacts in single cell
Using a 185 metre beamline at the Diamond synchrotron, researchers could see how Osmium, a rare precious metal that could be used for cancer treatments, reacts in a single human lung cancer cell. This is a major step forward in discovering new anti-cancer drugs for researchers at the University of Warwick.
Cell-Freezing Market to be transformed by University of Warwick Spin-Out CryoLogyx
The University of Warwick spin-out company, CryoLogyx, has been awarded £300k from InnovateUK to develop innovate cryopreservation agents with applications in the diagnostic, medicines discovery and cell-based therapy markets.
Soil bacteria hormone discovery provides fertile ground for new antibiotics
An international team of scientists working at the University of Warwick, UK, and Monash University, Australia, have determined the molecular basis of a biological mechanism that could enable more efficient and cost-effective production of existing antibiotics, and also allow scientists to uncover new antibiotics in soil bacteria.
University of Warwick scientist honoured for early career success in chemistry
Professor Matthew Gibson from University of Warwick’s Department of Chemistry and Warwick Medical has been awarded the 2021 McBain Medal by the Royal Society of Chemistry and the Society of Chemical Industry
High-rate Li-ion batteries demonstrate superior safety
As the inevitable growth of transport electrification continues, the types of batteries that will be used in such vehicles, their charging parameters, infrastructure and timeframes are key considerations that will speed up the transition to electrification. In the paper, ‘Determining the Limits and Effects of High-Rate Cycling on Lithium Iron Phosphate Cylindrical Cells’ published in and on the cover of the Journal Batteries, researchers from WMG, University of Warwick investigated the impacts on battery cell ageing from high current operation using commercial cells.
Chemical clues in leaves can reveal ash tree resistance to deadly disease
Naturally occurring compounds in ash leaves could be linked to susceptibility of individual trees to the fungal disease ash dieback (ADB). But selecting trees with lower levels of these compounds and breeding for resistance could leave the UK ash tree population open to attack from invading insect pests in the future, according to scientists at the University of Warwick.